Hester Biosciences gets nod to divest 43.81% stake in Texas Lifesciences [Healthcare]
AI Summary1 min read
TL;DR
Hester Biosciences, a poultry vaccine manufacturer, has received approval to sell a 43.81% stake in Texas Lifesciences, marking a significant divestment move in the healthcare sector.
Tags
Pharmaceuticals & DrugsHealthcareHester BiosciencesTexas Lifesciencesdivestmentpoultry vaccineshealthcare
Hester Biosciences was incorporated on April 29, 1987 as a Private Limited Company by the name of Hester Pharmaceuticals Limited. It was subsequently converted into a Public Limited Company on November 1, 1993. The company is engaged in the manufacturing of poultry vaccines. The company has been promoted by Rajiv D. Gandhi his brother Sanjiv D. Gandhi and Dr. Bhupendra V. Gandhi. The company changed its name to the present in 2008.